Clinical Trial

Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer

Study acronym: SURGYPET
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a diagnostic open-label, prospective, single-arm non-inferiority clinical trial. The primary endpoint is the accuracy to detect positive invasive margins in invasive ductal carcinoma (IDC) patients by high-resolution specimen Positron Emission Tomography/Computed Tomography (PET/CT) imaging.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06474975
Lead Sponsor European Institute of Oncology
Conditions Breast Cancer, Breast-conserving Surgery
Enrollment 150 participants
Start Date 2024-07
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-06-26